3. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity

Internal Medicine

Volumn 38, Issue 2, 1999, Pages 202-206

  Funahashi, Tohru ^a   Nakamura, Tadashi ^a   Shimomura, Iichiro ^a   Maeda, Kazuhisa ^a   Kuriyama, Hiroshi ^a   Takahashi, Masahiko ^a   Arita, Yukuio ^a   Kihara, Shinji ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adipocytokine; Plasminogen activator inhibitor 1; Visceral fat

Indexed keywords

ADIPONECTIN; COLLAGEN; CYTOKINE; DNA; PROTEIN; SIGNAL PEPTIDE;

ADIPOSE TISSUE; ARTERIOSCLEROSIS; GENETICS; HUMAN; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW; RISK FACTOR; VISCERA;

ADIPONECTIN; ADIPOSE TISSUE; ARTERIOSCLEROSIS; COLLAGEN; CYTOKINES; DNA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; PROTEINS; RISK FACTORS; VISCERA;

EID: 0033071540     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.202     Document Type: Article

References (14)

1. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54: 254-260, 1982.
2. Larsson B, Svardsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J Clin Res Ed 288: 1401-1404, 1984.
3. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36: 54-59, 1987.
4. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107: 239-246, 1994.
5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
6. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149: 1514-1520, 1989.
7. Kuriyama H, Yamashita S, Shimomura I, et al. Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein mRNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology 27: 557-562, 1997.
8. Maeda K, Okubo K, Shimomura I, et al. Analysis of an expression profile of genes in the human adipose tissue. Gene 190: 227-235, 1997.
9. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
10. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.
11. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med 2: 800-803, 1996.
12. Funahashi T, Shimomura I, Hiraoka H, et al. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun 211: 469-475, 1995.
13. Takahashi M, Funahashi T, Shimomura I, et al. Plasma leptin and body fat distribution. Horm Metab Res 28: 751-752, 1996.
14. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Mose Abundant gene transcript 1). Biochem Biophys Res Commun 221: 286-289, 1996.